National Asset Management, Inc. Alvotech Transaction History
National Asset Management, Inc.
- $2.94 Billion
- Q4 2024
A detailed history of National Asset Management, Inc. transactions in Alvotech stock. As of the latest transaction made, National Asset Management, Inc. holds 10,395 shares of ALVO stock, worth $117,463. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,395
Previous 50,000
79.21%
Holding current value
$117,463
Previous $595,000
76.97%
% of portfolio
0.0%
Previous 0.02%
Shares
3 transactions
Others Institutions Holding ALVO
# of Institutions
44Shares Held
14.5MCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA3.2MShares$36.1 Million0.0% of portfolio
-
Bracebridge Capital, LLC2.71MShares$30.6 Million5.53% of portfolio
-
Howard Marks Oaktree Capital Management LP | Los Angeles, Ca1.93MShares$21.8 Million0.65% of portfolio
-
Morgan Stanley New York, NY1.48MShares$16.7 Million0.0% of portfolio
-
Littlejohn & CO LLC1.32MShares$14.9 Million7.91% of portfolio
About Alvotech
- Ticker ALVO
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 248,650,000
- Market Cap $2.81B
- Description
- Alvotech, through its subsidiaries, develops and manufactures biosimilar medicines for patients worldwide. It offers biosimilar products in the therapeutic areas of autoimmune, eye, and bone disorders, as well as cancer. The company's lead program is AVT02, a high concentration formulation biosimilar to Humira to treat various inflammatory condi...